These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2060531)

  • 41. In vitro studies of Pneumocystis carinii.
    Cushion MT
    J Protozool; 1989; 36(1):45-52. PubMed ID: 2651655
    [No Abstract]   [Full Text] [Related]  

  • 42. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.
    Maschmeyer G; Helweg-Larsen J; Pagano L; Robin C; Cordonnier C; Schellongowski P;
    J Antimicrob Chemother; 2016 Sep; 71(9):2405-13. PubMed ID: 27550993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Korraa H; Saadeh C
    South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pneumocystis carinii pneumonia treatment in people infected with HIV.
    Bellamy R
    Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
    [No Abstract]   [Full Text] [Related]  

  • 45. Persistence of trophozoites after successful treatment of Pneumocystis carinii pneumonia.
    el-Sadr W; Sidhu G
    Ann Intern Med; 1986 Dec; 105(6):889-90. PubMed ID: 3490813
    [No Abstract]   [Full Text] [Related]  

  • 46. Incorporation of fatty acids and amino acids by cultured Pneumocystis carinii.
    Paulsrud JR; Queener SF
    J Eukaryot Microbiol; 1994; 41(6):633-8. PubMed ID: 7866387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
    González-García J; Rubio García R; Antela López A; García Alcaide F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention and treatment of Pneumocystis carinii pneumonia.
    Hughes WT
    Annu Rev Med; 1991; 42():287-95. PubMed ID: 2035974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
    Deresinski SC
    Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
    Kovacs JA; Gill VJ; Meshnick S; Masur H
    JAMA; 2001 Nov; 286(19):2450-60. PubMed ID: 11712941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical Pneumocystis carinii infection in AIDS: massive cervical lymphadenitis and fever of unknown origin.
    Kallen AJ; Wallace MR
    South Med J; 1998 Aug; 91(8):759-60. PubMed ID: 9715224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human immunodeficiency virus protease inhibitors and Pneumocystis carinii.
    Atzori C; Cargnel A
    J Infect Dis; 2002 Jun; 185(11):1692-3; author reply 1693-4. PubMed ID: 12023783
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of short-term cultures of Pneumocystis for drug testing.
    Sahm M; Wingen F; Seitz HM
    Appl Parasitol; 1996 Jan; 37(1):45-53. PubMed ID: 8574247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis carinii.
    Ball MD; Bartlett MS; Shaw M; Smith JW; Nasr M; Meshnick SR
    Antimicrob Agents Chemother; 2001 May; 45(5):1473-9. PubMed ID: 11302813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental P. carinii pneumonia.
    Contini C; Angelici E; Canipari R
    J Antimicrob Chemother; 1999 Feb; 43(2):301-4. PubMed ID: 11252340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of effect of prophylactic aerosolized pentamidine on the detection of Pneumocystis carinii in induced sputum or bronchoalveolar lavage specimens.
    Ng VL; Geaghan SM; Leoung G; Shiboski S; Fahy J; Schnapp L; Yajko DM; Hopewell PC; Hadley WK
    Arch Pathol Lab Med; 1993 May; 117(5):493-6. PubMed ID: 8489338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo.
    Walzer PD; Ashbaugh A; Collins M; Cushion MT
    J Infect Dis; 2001 Nov; 184(10):1355-7. PubMed ID: 11679930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii.
    Atzori C; Angeli E; Mainini A; Agostoni F; Micheli V; Cargnel A
    J Infect Dis; 2000 May; 181(5):1629-34. PubMed ID: 10823762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
    Safrin S
    Semin Respir Infect; 1993 Jun; 8(2):96-103. PubMed ID: 8278684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.